BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. (2016). Mediterranean Journal of Hematology and Infectious Diseases, 8, e2016011. https://doi.org/10.4084/mjhid.2016.011